Rebecca Bair

Rebecca Bair has a diverse background in the life science industry, starting as an undergraduate researcher at the University of California, Berkeley with a focus on Mycobacterium tuberculosis biology and drug resistance. Rebecca also has experience as a Staff Research Associate at the University of California, San Francisco working in the Clinical Neuroimmunology field. Rebecca has also worked as an ATP Analyst at EVEXIA Bio Fund, where Rebecca performed scientific diligence and financial analysis on biotech companies. With their background in molecular and cell biology, specifically in neurobiology, Rebecca's roles as a Life Science Analyst at DeciBio Consulting highlight their expertise in providing strategic insights for the personalized medicine industry.